secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0001104659-23-033300
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chief Medical Officer Mythili Koneru resigns effective April 9, 2023
--------------------------------------------------------------------

- Mythili Koneru notified Marker Therapeutics of her resignation as Chief Medical Officer, effective April 9, 2023.
- No replacement or interim successor has been announced by the company.
- The departure removes a key clinical oversight role from the biotech firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923033300/0001104659-23-033300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923033300/tm239491d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-033300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer